G9a promotes immune suppression by targeting the Fbxw7/Notch pathway in glioma stem cells

AIM: Immunotherapy for glioblastoma multiforme (GBM) is limited because of a strongly immunosuppressive tumor microenvironment (TME). Remodeling the immune TME is an effective strategy to eliminate GBM immunotherapy resistance. Glioma stem cells (GSCs) are inherently resistant to chemotherapy and ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Yufei, Liu, Bin, Cai, Lize, Li, Yanyan, Huang, Yulun, Zhou, Youxin, Sun, Xingjian, Yang, Wei, Sun, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401078/
https://www.ncbi.nlm.nih.gov/pubmed/36971192
http://dx.doi.org/10.1111/cns.14191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401078/
https://www.ncbi.nlm.nih.gov/pubmed/36971192
http://dx.doi.org/10.1111/cns.14191

Ejemplares similares